Sotex

Sotex is a leading Russian pharmaceutical manufacturer and the core production asset of the Protek Group. Founded in 1999, the company operates a high-tech facility in the Moscow region that was among the first in the country to be built in full compliance with international GMP standards. Sotex focuses on the development and production of high-quality generic and innovative medicines, with a strong emphasis on injectable formulations and biosimilars. Its diverse portfolio covers critical therapeutic areas including neurology, rheumatology, oncology, and nephrology. In addition to its own brands, Sotex is a major provider of contract manufacturing services for global pharmaceutical companies seeking to localize production in the Russian market. The company maintains a significant presence in Russia and the CIS region through its extensive distribution network.